File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/S0006-8993(97)00751-8
- Scopus: eid_2-s2.0-0030931659
- PMID: 9359618
- WOS: WOS:A1997XX88900038
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Swelling and damage of glial cells by lactacidosis and glutamate: Effect of α-trinositol
Title | Swelling and damage of glial cells by lactacidosis and glutamate: Effect of α-trinositol |
---|---|
Authors | |
Keywords | α-Trinositol C6 glioma Cell swelling Glutamate Lactacidosis |
Issue Date | 1997 |
Publisher | Elsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/brainres |
Citation | Brain Research, 1997, v. 766 n. 1-2, p. 285-288 How to Cite? |
Abstract | The therapeutical efficacy of α-trinositol (D-myo-inositol-1,2,6- trisphosphate), an isomer of the intracellular messenger IP3, was analyzed on cytotoxic swelling and damage of glial cells in vitro from lactacidosis or glutamate. C6 glioma cells suspended in a physiological medium were either exposed to pH 5.0 by administration of lactic acid, or to 1 mM glutamate. Cell swelling and viability were quantified by flow cytometry. Lactacidosis of pH 5.0 led to an increase in cell volume to 139.7 ± 1.3% within 20 min whereas α-trinositol was reducing the swelling response by approximately 25% (P < 0.01). In addition, at pH 5.0 the fraction of viable cells was lowered from 94.3 ± 0.2% (control) to only 53.8 ± 3.1% after 60 min. α-Trinositol was found to protect also cell viability; at 60 min of lactacidosis 70.2 ± 1.6% of the cells still were viable (P < 0.01). The addition of glutamate (1 mM) to the cell suspension led to a steady increase in cell size, reaching 110% of control at 120 min, irrespectively of whether α-trinositol was added or not. |
Persistent Identifier | http://hdl.handle.net/10722/149562 |
ISSN | 2023 Impact Factor: 2.7 2023 SCImago Journal Rankings: 0.832 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Staub, F | en_US |
dc.contributor.author | Peters, J | en_US |
dc.contributor.author | Plesnila, N | en_US |
dc.contributor.author | Chang, RCC | en_US |
dc.contributor.author | Baethmann, A | en_US |
dc.date.accessioned | 2012-06-26T05:55:18Z | - |
dc.date.available | 2012-06-26T05:55:18Z | - |
dc.date.issued | 1997 | en_US |
dc.identifier.citation | Brain Research, 1997, v. 766 n. 1-2, p. 285-288 | en_US |
dc.identifier.issn | 0006-8993 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/149562 | - |
dc.description.abstract | The therapeutical efficacy of α-trinositol (D-myo-inositol-1,2,6- trisphosphate), an isomer of the intracellular messenger IP3, was analyzed on cytotoxic swelling and damage of glial cells in vitro from lactacidosis or glutamate. C6 glioma cells suspended in a physiological medium were either exposed to pH 5.0 by administration of lactic acid, or to 1 mM glutamate. Cell swelling and viability were quantified by flow cytometry. Lactacidosis of pH 5.0 led to an increase in cell volume to 139.7 ± 1.3% within 20 min whereas α-trinositol was reducing the swelling response by approximately 25% (P < 0.01). In addition, at pH 5.0 the fraction of viable cells was lowered from 94.3 ± 0.2% (control) to only 53.8 ± 3.1% after 60 min. α-Trinositol was found to protect also cell viability; at 60 min of lactacidosis 70.2 ± 1.6% of the cells still were viable (P < 0.01). The addition of glutamate (1 mM) to the cell suspension led to a steady increase in cell size, reaching 110% of control at 120 min, irrespectively of whether α-trinositol was added or not. | en_US |
dc.language | eng | en_US |
dc.publisher | Elsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/brainres | en_US |
dc.relation.ispartof | Brain Research | en_US |
dc.subject | α-Trinositol | - |
dc.subject | C6 glioma | - |
dc.subject | Cell swelling | - |
dc.subject | Glutamate | - |
dc.subject | Lactacidosis | - |
dc.subject.mesh | Acidosis, Lactic - Physiopathology | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Anti-Inflammatory Agents, Non-Steroidal - Pharmacology | en_US |
dc.subject.mesh | Cell Size - Drug Effects | en_US |
dc.subject.mesh | Cell Survival - Drug Effects | en_US |
dc.subject.mesh | Glioma | en_US |
dc.subject.mesh | Glutamic Acid - Pharmacology | en_US |
dc.subject.mesh | Inositol 1,4,5-Trisphosphate - Metabolism | en_US |
dc.subject.mesh | Inositol Phosphates - Pharmacology | en_US |
dc.subject.mesh | Neuroglia - Drug Effects - Pathology | en_US |
dc.subject.mesh | Tumor Cells, Cultured - Drug Effects - Pathology | en_US |
dc.title | Swelling and damage of glial cells by lactacidosis and glutamate: Effect of α-trinositol | en_US |
dc.type | Article | en_US |
dc.identifier.email | Chang, RCC:rccchang@hkucc.hku.hk | en_US |
dc.identifier.authority | Chang, RCC=rp00470 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1016/S0006-8993(97)00751-8 | en_US |
dc.identifier.pmid | 9359618 | - |
dc.identifier.scopus | eid_2-s2.0-0030931659 | en_US |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-0030931659&selection=ref&src=s&origin=recordpage | en_US |
dc.identifier.volume | 766 | en_US |
dc.identifier.issue | 1-2 | en_US |
dc.identifier.spage | 285 | en_US |
dc.identifier.epage | 288 | en_US |
dc.identifier.isi | WOS:A1997XX88900038 | - |
dc.publisher.place | Netherlands | en_US |
dc.identifier.scopusauthorid | Staub, F=7006611117 | en_US |
dc.identifier.scopusauthorid | Peters, J=7404191248 | en_US |
dc.identifier.scopusauthorid | Plesnila, N=7003609441 | en_US |
dc.identifier.scopusauthorid | Chang, RCC=7403713410 | en_US |
dc.identifier.scopusauthorid | Baethmann, A=7004994793 | en_US |
dc.identifier.issnl | 0006-8993 | - |